Vibativ (Theravance Biopharma R&D, Inc.)
Welcome to the PulseAid listing for the Vibativ drug offered from Theravance Biopharma R&D, Inc.. This Lipoglycopeptide Antibacterial [EPC],Lipoglycopeptides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Theravance Biopharma R&D, Inc. |
NON-PROPRIETARY NAME: | telavancin hydrochloride |
SUBSTANCE NAME: | TELAVANCIN HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Lipoglycopeptide Antibacterial [EPC],Lipoglycopeptides [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-11-05 |
END MARKETING DATE: | 0000-00-00 |
Vibativ HUMAN PRESCRIPTION DRUG Details:
Item Description | Vibativ from Theravance Biopharma R&D, Inc. |
LABELER NAME: | Theravance Biopharma R&D, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 15(mg/mL) |
START MARKETING DATE: | 2009-11-05 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 62847-001_3acb805d-4fe0-4f56-9c7d-a4c2bd9eb8aa |
PRODUCT NDC: | 62847-001 |
APPLICATION NUMBER: | NDA022110 |
Other TELAVANCIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: